Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Cross

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Biochimica Et Biophysica Acta|January 20, 1998
Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridinM J Cross, M N Hodgkin, J A Plumb, et al.
Advances in Pharmacology (San Diego, Calif.)|July 11, 2012
Human pluripotent stem cells for modeling toxicityR L C Sison-Young, R Kia, J Heslop, et al.
Osteoarthritis and Cartilage|April 20, 2004
Two knees or not two knees? Patient costs and outcomes following bilateral and unilateral total knee joint replacement surgery for OAL M March, M Cross, K L Tribe, et al.
South African Journal of Sports Medicine|November 5, 2024
End-to-end SARS-CoV-2 transmission risks in sport: Current evidence and practical recommendationsB Jones, G Phillips, F Valeriani, et al.
British Journal of Pharmacology|October 11, 2014
Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injuryM J Cross, B R Berridge, P J M Clements, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Biochimica Et Biophysica Acta|January 20, 1998
Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridinM J Cross, M N Hodgkin, J A Plumb, et al.
Advances in Pharmacology (San Diego, Calif.)|July 11, 2012
Human pluripotent stem cells for modeling toxicityR L C Sison-Young, R Kia, J Heslop, et al.
Osteoarthritis and Cartilage|April 20, 2004
Two knees or not two knees? Patient costs and outcomes following bilateral and unilateral total knee joint replacement surgery for OAL M March, M Cross, K L Tribe, et al.
South African Journal of Sports Medicine|November 5, 2024
End-to-end SARS-CoV-2 transmission risks in sport: Current evidence and practical recommendationsB Jones, G Phillips, F Valeriani, et al.
British Journal of Pharmacology|October 11, 2014
Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injuryM J Cross, B R Berridge, P J M Clements, et al.
Pageof 8